Hepatitis B Surface Antigen Seroprevalence of Turkish and Foreign Patients of Reproductive Age in 2014-2017
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 1
Abstract
Objectives: Cross-country migration may affect the prevalence of hepatitis B virus (HBV). Due to the recent war in Syria, there has been a serious exodus towards Turkey. In this study, it was aimed to investigate the hepatitis B surface antigen (HBsAg) seroprevalence among women of reproductive age of foreign origin, both Turkish and mostly Syrian immigrants. Materials and Methods: In this study, we retrospectively evaluated the HBsAg results of 55.057 patients, mostly pregnant and aged between 15 and 49 years who presented to a Maternity and Children Hospital between January 1st, 2014, and December 31st, 2017. Results: In both Turkish and foreign origin patients, the seropositivity of HBsAg was found to be 1.1%. However, in women over 40, those of foreign origin were higher than Turkish women. Conclusion: Our region is low endemicity in terms of HBsAg seroprevalence in women of reproductive age. In addition, women of foreign origin are not different than women of Turkish origin in this respect. However, in future years, the migrant population may be disadvantaged if they do not receive adequate health care.
Authors and Affiliations
Ayşegül Erdoğan, Kübra Yıldız, Ahmet Rıza Şahin, Sevinç Özden, Ramazan Azim Okyay
Intravenous Drug Use Rates and Results of Direct-acting Antiviral Treatment in Prisoner Patients
Objectives: Intravenous drug use (IVDU) is more common in prisoner patients, and this is a global problem. Hepatitis C virus (HCV) infection is higher in prisoners than general population. In our study, we aimed to exami...
Relationship Between Basic Laboratory Results and Fibrosis in Chronic Hepatitis B Patients
Objectives: Liver biopsy (LB) is an important cornerstone in decision to start treatment for chronic hepatitis B (HB). Viral load and liver function tests are performed to determine the most appropriate time. In this stu...
The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience
Objectives: Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir (PrOD) seems to be highly effective and safe in chronic haemodialysis (CHD) patients. We presented our experiences of treatment with PrOD in CHD patients. Material...
The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon + Ribavirin
Objectives: Directly-acting anti-viral agents for the treatment of hepatitis C have been revolutionised. In the meantime, hepatitis C patients with sustained virologic response (SVR) achieved with previous treatments hav...
Hepatitis C Virus Genotype Distribution in Forensic Cases
Objectives: In this study, we aimed to determine the hepatitis C virus (HCV) genotype and subtypes in blood samples that were determined by polymerase chain reaction (PCR) in autopsy cases. Materials and Methods: The bl...